Outcomes of patients with HER2-negative metastatic breast cancer after platinum- and non-platinum-based first-line chemotherapy among patients with and without pathogenic germline BRCA1/2 mutations.
Saved in:
| Title: | Outcomes of patients with HER2-negative metastatic breast cancer after platinum- and non-platinum-based first-line chemotherapy among patients with and without pathogenic germline BRCA1/2 mutations. |
|---|---|
| Authors: | Jacot, William1 (AUTHOR) William.Jacot@icm.unicancer.fr, Lusque, Amélie2 (AUTHOR), Vicier, Cécile3 (AUTHOR), Mailliez, Audrey4 (AUTHOR), de La Motte Rouge, Thibault5 (AUTHOR), Cabel, Luc6 (AUTHOR), Levy, Christelle7 (AUTHOR), Patsouris, Anne8 (AUTHOR), Desmoulins, Isabelle9 (AUTHOR), Uwer, Lionel10 (AUTHOR), Thery, Jean-Christophe11 (AUTHOR), Robain, Mathieu12 (AUTHOR), Caron, Olivier13 (AUTHOR), Tredan, Olivier14 (AUTHOR), Filleron, Thomas2 (AUTHOR), Frenel, Jean-Sébastien15 (AUTHOR), Delaloge, Suzette13 (AUTHOR) |
| Source: | British Journal of Cancer. Nov2022, Vol. 127 Issue 11, p1963-1973. 11p. |
| Database: | Academic Search Ultimate |
| ISSN: | 00070920 |
|---|---|
| DOI: | 10.1038/s41416-022-02003-1 |
